The release of prion protein from platelets during storage of apheresis platelets

Transfusion

Volumn 41, Issue 1, 2001, Pages 61-66

  Bessos, Hagop ^a,b   Drummond, Olive ^a   Prowse, Chris ^a   Turner, Marc ^a   MacGregor, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b National Science Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; PADGEM PROTEIN; PRION PROTEIN;

APHERESIS; ARTICLE; BLOOD STORAGE; ERYTHROCYTE PRESERVATION; FLUOROIMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; PROTEIN SECRETION; THROMBOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION;

BETA-THROMBOGLOBULIN; BLOOD PLATELETS; BLOOD PRESERVATION; CHEMICAL FRACTIONATION; HUMANS; L-LACTATE DEHYDROGENASE; PLATELET COUNT; PLATELETPHERESIS; PRPC PROTEINS;

EID: 0035122489     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41010061.x     Document Type: Article

References (30)

1. Neuropathological findings in new variant CJD and experimental transmission of BSE
2. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
3. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets
4. Deadly conformations: Protein misfolding in prion disease
5. Scottish centre for infection and environmental health
6. A crucial role for B cells in neuroinvasive scrapie
7. PrP expression in B lymphocytes is not required for prion neuroinvasion
8. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells
9. Creutzfeldt-Jakob disease and transfusion safety: Tilting at icebergs?
10. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: Analysis of epidemiological surveillance data for 1970-96
11. The impact of new variant Creutzfeldt Jakob disease on blood transfusion practice
12. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease
13. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
14. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
15. Prion protein release during storage of apheresis platelet concentrate
16. Lanthanides as probes for time-resolved fluorometric immunoassays
17. The release of a human platelet specific protein measured by radioimmunoaasay
18. Prion protein released by platelets
19. Glycoproteins Ib and IIb/IIIa in the quality assessment of platelet concentrates during storage
20. Quality of platelet concentrates irradiated with UVB light: Effect of UV dose and dose rate on glycocalicin release and correlation with other markers of the platelet storage lesion
21. Annexin V: A new marker of platelet storage lesion - Correlation with dMPV
22. c) within human platelets
23. The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible
24. Thrombopoeitin: From theory to reality
25. Preliminary assessment of whole-blood, red-cell and platelet-leucodepleting filters for possible induction of prion release by leucocyte fragmentation during room temperature processing
26. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy
27. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
28. Use of capillary electrophoresis and fluorescent labelled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy